title: Carbamazepine and physostigmine eyedrops in the treatment of early alcohol withdrawal and alcohol-related hypertension.
authors.forename: A
authors.initials: A
authors.lastname: Stojek
authors.forename: A
authors.initials: A
authors.lastname: Bilikiewicz
authors.forename: A
authors.initials: A
authors.lastname: Lerch
mesh_terms: D000328:Adult; D002220:Carbamazepine / Q000008:administration & dosage*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D000431:Ethanol / Q000009:adverse effects*; D006801:Humans; D006973:Hypertension / Q000139:chemically induced* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009883:Ophthalmic Solutions; D010830:Physostigmine / Q000008:administration & dosage*; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*
chemical_list: D009883:Ophthalmic Solutions; D002220:Carbamazepine; D000431:Ethanol; D010830:Physostigmine